Dietary Flavonoids May Help in Managing CF Through Impact on Gut Bacteria, Small Study Suggests
Sep 21, 2018 08:00 am | Ana Pena
Consuming dietary flavonoids — compounds naturally found in fruits, vegetables, chocolate, and beverages like wine and tea — may be associated with changes in gut bacteria that potentially affect the body’s metabolism, immune function, and inflammation in patients with cystic fibrosis (CF), a small study reports. The flavonoid-related changes in the gut microbiota may influence the management […]
The post Dietary Flavonoids May Help in Managing CF Through Impact on Gut Bacteria, Small Study Suggests appeared first on Cystic Fibrosis News Today. |
|
FDA Gives Green Light to 2 Trials for AB-PA01, Potential Therapy Against P. aeruginosa Infections
Sep 20, 2018 07:00 am | Jose Marques Lopes, PhD
The U.S. Food and Drug Administration gave positive feedback to the design of AmpliPhi Biosciences’ two proposed clinical trials of its Pseudomonas aeruginosa-targeting treatment candidate AB-PA01, the company announced in a press release. P. aeruginosa is the major cause of lung infections in cystic fibrosis patients. AB-PA01 is an investigational therapy based on bacteriophages, which are […]
The post FDA Gives Green Light to 2 Trials for AB-PA01, Potential Therapy Against P. aeruginosa Infections appeared first on Cystic Fibrosis News Today. |
|
Worthwhile Experiences at BreatheCon, a Virtual CF Conference
Sep 19, 2018 03:00 pm | Ella Balasa
BreatheCon is a free online conference hosted by the Cystic Fibrosis Foundation (CFF) for CF patients 18 or older from across the globe to share life experiences, ideas, and encouragement. I have attended this incredible annual event since its inception in 2016. It has been uplifting to hear from keynote speakers who have faced tremendous adversities […]
The post Worthwhile Experiences at BreatheCon, a Virtual CF Conference appeared first on Cystic Fibrosis News Today. |
|
|
No hay comentarios:
Publicar un comentario